Market Overview:
The global diabetes care devices and drugs market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, rising awareness about diabetes care, and technological advancements in diabetes care devices. The insulin segment is expected to dominate the global diabetes care devices and drugs market during the forecast period. This segment is expected to grow at a CAGR of 7.8% from 2018 to 2030 due to the increasing incidence of type 1 and type 2 diabetes across the globe.
Product Definition:
Diabetes care devices and drugs are important for the treatment of diabetes. They help to control blood sugar levels and manage the symptoms of diabetes.
Insulin:
Insulin is a hormone, which facilitates the entry of glucose into the blood cells. Insufficient production of insulin by pancreas due to lack of stimulation or absence of pancreatic hormones leads to diabetes mellitus. The primary function of insulin is to enable glucose uptake by cells for energy production.
Rapid Acting Insulin:
Rapid acting insulin is a short-acting form of human insulin. It usually works within 15 to 45 minutes and has a shorter duration of action than long-acting analogs. The drug class also includes rapid acting premixed insulin, premixed analog, and regular mixed (rM) insulins.
Application Insights:
In 2017, the hospital application segment dominated the market for diabetes care devices and drugs with a revenue share of over 80%. The hospital is considered to be one of the most important places for medical management of diabetes. It houses a large number of patients suffering from various diabetic complications. Hence, it has become an essential part in providing effective treatment to such patients. This factor is anticipated to fuel product demand in near future as well.
The household application segment accounted for 19% share in 2017 and is expected to grow at a significant rate during the forecast period owing to increasing awareness about self-management.
Regional Analysis:
North America dominated the global diabetes care devices & drugs market in 2017. The presence of a large number of manufacturers, suppliers, and brands coupled with high healthcare expenditure levels in this region are some factors that can be attributed to its large share. Moreover, technological advancements such as miniaturization and automation of insulin delivery systems have further contributed to its growth.
Asia Pacific is expected to grow at the fastest rate during the forecast period owing to increasing diabetic population along with rising disposable income levels in emerging economies such as China and India.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. As a result, there is a growing demand for diabetes care devices and drugs to manage the condition effectively.
- Technological advancements: Diabetes care devices are becoming increasingly sophisticated with each passing day, thanks to technological advancements. This has led to increased adoption of these devices by people with diabetes, thereby driving market growth.
- Growing awareness about diabetes: There is a growing awareness about diabetes among people across the world due to increasing incidences of the disease globally. This has led to an increase in demand for effective diagnosis and treatment options, including diabetic care devices and drugs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetes Care Devices & Drugs Market Research Report
By Type
Insulin, Rapid Acting Insulin, Short Acting Insulin, Diabetes Care Devices, Diabetes Monitoring Devices, Other
By Application
Hospital, Household
By Companies
Abbott Laboratories, Ascensia Diabetes Care Holdings, AstraZeneca, Boehringer Ingelheim GmbH, Eli Lilly And, Hoffmann-La Roche, Johnson & Johnson, Medtronic PLC, Novartis, Novo Nordisk A/S, Ypsomed, Terumo
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Diabetes Care Devices & Drugs Market Report Segments:
The global Diabetes Care Devices & Drugs market is segmented on the basis of:
Types
Insulin, Rapid Acting Insulin, Short Acting Insulin, Diabetes Care Devices, Diabetes Monitoring Devices, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Household
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Ascensia Diabetes Care Holdings
- AstraZeneca
- Boehringer Ingelheim GmbH
- Eli Lilly And
- Hoffmann-La Roche
- Johnson & Johnson
- Medtronic PLC
- Novartis
- Novo Nordisk A/S
- Ypsomed
- Terumo
Highlights of The Diabetes Care Devices & Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Insulin
- Rapid Acting Insulin
- Short Acting Insulin
- Diabetes Care Devices
- Diabetes Monitoring Devices
- Other
- By Application:
- Hospital
- Household
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetes Care Devices & Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diabetes care devices and drugs are used to help manage diabetes. Devices include insulin pumps, blood glucose meters, and other medical equipment. Drugs used to treat diabetes include oral medications such as metformin or sulfonylureas, injectable medications such as insulin or glucagon, and non-insulin medication therapies such as sulphonylurea inhibitors.
Some of the key players operating in the diabetes care devices & drugs market are Abbott Laboratories, Ascensia Diabetes Care Holdings, AstraZeneca, Boehringer Ingelheim GmbH, Eli Lilly And, Hoffmann-La Roche, Johnson & Johnson, Medtronic PLC, Novartis, Novo Nordisk A/S, Ypsomed, Terumo.
The diabetes care devices & drugs market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Diabetes Care Devices & Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Diabetes Care Devices & Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Diabetes Care Devices & Drugs Market - Supply Chain
4.5. Global Diabetes Care Devices & Drugs Market Forecast
4.5.1. Diabetes Care Devices & Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Diabetes Care Devices & Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Diabetes Care Devices & Drugs Market Absolute $ Opportunity
5. Global Diabetes Care Devices & Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Diabetes Care Devices & Drugs Market Size and Volume Forecast by Type
5.3.1. Insulin
5.3.2. Rapid Acting Insulin
5.3.3. Short Acting Insulin
5.3.4. Diabetes Care Devices
5.3.5. Diabetes Monitoring Devices
5.3.6. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Diabetes Care Devices & Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Diabetes Care Devices & Drugs Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Household
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Diabetes Care Devices & Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Diabetes Care Devices & Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Diabetes Care Devices & Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Diabetes Care Devices & Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Diabetes Care Devices & Drugs Demand Share Forecast, 2019-2026
9. North America Diabetes Care Devices & Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Diabetes Care Devices & Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Diabetes Care Devices & Drugs Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Household
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Diabetes Care Devices & Drugs Market Size and Volume Forecast by Type
9.7.1. Insulin
9.7.2. Rapid Acting Insulin
9.7.3. Short Acting Insulin
9.7.4. Diabetes Care Devices
9.7.5. Diabetes Monitoring Devices
9.7.6. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Diabetes Care Devices & Drugs Demand Share Forecast, 2019-2026
10. Latin America Diabetes Care Devices & Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Diabetes Care Devices & Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Diabetes Care Devices & Drugs Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Household
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Diabetes Care Devices & Drugs Market Size and Volume Forecast by Type
10.7.1. Insulin
10.7.2. Rapid Acting Insulin
10.7.3. Short Acting Insulin
10.7.4. Diabetes Care Devices
10.7.5. Diabetes Monitoring Devices
10.7.6. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Diabetes Care Devices & Drugs Demand Share Forecast, 2019-2026
11. Europe Diabetes Care Devices & Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Diabetes Care Devices & Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Diabetes Care Devices & Drugs Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Household
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Diabetes Care Devices & Drugs Market Size and Volume Forecast by Type
11.7.1. Insulin
11.7.2. Rapid Acting Insulin
11.7.3. Short Acting Insulin
11.7.4. Diabetes Care Devices
11.7.5. Diabtes Monitoring Devices
11.7.6. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Diabetes Care Devices & Drugs Demand Share, 2019-2026
12. Asia Pacific Diabetes Care Devices & Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Diabetes Care Devices & Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Diabetes Care Devices & Drugs Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Household
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Diabetes Care Devices & Drugs Market Size and Volume Forecast by Type
12.7.1. Insulin
12.7.2. Rapid Acting Insulin
12.7.3. Short Acting Insulin
12.7.4. Diabetes Care Devices
12.7.5. Diabetes Monitoring Devices
12.7.6. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Diabetes Care Devices & Drugs Demand Share, 2019-2026
13. Middle East & Africa Diabetes Care Devices & Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Diabetes Care Devices & Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Diabetes Care Devices & Drugs Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Household
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Diabetes Care Devices & Drugs Market Size and Volume Forecast by Type
13.7.1. Insulin
13.7.2. Rapid Acting Insulin
13.7.3. Short Acting Insulin
13.7.4. Diabetes Care Devices
13.7.5. Diabetes Monitoring Devices
13.7.6. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Diabetes Care Devices & Drugs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Diabetes Care Devices & Drugs Market: Market Share Analysis
14.2. Diabetes Care Devices & Drugs Distributors and Customers
14.3. Diabetes Care Devices & Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Ascensia Diabetes Care Holdings
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. AstraZeneca
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Boehringer Ingelheim GmbH
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Eli Lilly And
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Hoffmann-La Roche
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Johnson & Johnson
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Medtronic PLC
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Novartis
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Novo Nordisk A/S
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Ypsomed
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Terumo
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
